Exploring the efficacy and safety of cannabidiol in individuals with epilepsy: an umbrella review of meta-analyses and systematic reviews-Reference-Cited by-同舟云学术

Exploring the efficacy and safety of cannabidiol in individuals with epilepsy: an umbrella review of meta-analyses and systematic reviews

Published:2024-08-21 Issue: Volume: Page:
ISSN:0925-4692
Container-title:Inflammopharmacology
language:en
Short-container-title:Inflammopharmacol

Author:

Abbasi Hamid^ORCID,Abbasi Mohammad Mehdi^ORCID,Pasand Mohammadjavad^ORCID,Mohtadi Mahshad^ORCID,Bakhshimoghaddam Farnush^ORCID,Eslamian Ghazaleh^ORCID

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s10787-024-01523-x.pdf

Reference40 articles.

1. Bilbao A, Spanagel R (2022) Medical cannabinoids: a pharmacology-based systematic review and meta-analysis for all relevant medical indications. BMC Med 20(1):259

2. Burgos B, Cigarroa I, Toloza-Ramírez D (2023) Effectiveness and safety profile of oral cannabis preparations for the treatment of refractory epilepsies in infant-young population: a scoping review. Rev Ecuat Neurol 32(1):62–74

3. Cochran WG (1954) The combination of estimates from different experiments. Biometrics 10(1):101–129

4. Devinsky O, Cilio MR, Cross H, Fernandez-Ruiz J, French J, Hill C, Katz R, Di Marzo V, Jutras-Aswad D, Notcutt WG, Martinez-Orgado J, Robson PJ, Rohrback BG, Thiele E, Whalley B, Friedman D (2014) Cannabidiol: pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders. Epilepsia 55(6):791–802. https://doi.org/10.1111/epi.12631

5. Devinsky O, Cross JH, Laux L, Marsh E, Miller I, Nabbout R, Scheffer IE, Thiele EA, Wright S (2017) Trial of cannabidiol for drug-resistant seizures in the Dravet syndrome. N Engl J Med 376(21):2011–2020